FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2892091729> ?p ?o ?g. }

• W2892091729 endingPage "21" @default.
• W2892091729 startingPage "16" @default.
• W2892091729 abstract "<b><i>Background:</i></b> Diabetes is the leading cause of end-stage renal disease (ESRD) worldwide. Also, diabetes is prevalent in kidney transplant recipients for nondiabetic reasons. <b><i>Methodology:</i></b> We used a mixed method methodology, including a case report, surveys of physicians’ opinions, and a review of the literature. <b><i>Results:</i></b> (A) A 58-year-old retired police officer was seen at the diabetes clinic in October 2015. His care was transferred from another physician who had relocated elsewhere. The patient’s medical history included type 2 diabetes for over 25 years, hyperlipidemia, hypertension, diabetic neuropathy, diabetic nephropathy, and diabetic retinopathy in addition to vitamin D deficiency and morbid obesity. He had received a renal transplant from a nonrelated live donor 7 years previously. His medications included sitagliptin 50 mg/day, gliclazide (modified release) 60–90 mg/day, metformin (extended release) 750 mg twice daily, and dapagliflozin 10 mg/day. We focus on the off-license use of dapagliflozin in a patient with a history of ESRD and renal transplantation. The lack of published experience with sodium-glucose cotransporter 2 (SGLT2) inhibitors in renal transplant recipients was discussed with him. “But I came to no harm,” was his reply. His records on renal function, hydration status, and glycemic control all seemed unaffected over the previous 2.5 years. He remains well till the time of this report. Serum electrolytes, creatinine, plasma albumin, hemoglobin, packed cell volume, and estimated glomerular filtration rate (eGFR) were not adversely affected. Glycated hemoglobin and fasting blood glucose were stable. Urine was consistently negative for ketones but loaded with glycosuria. It was agreed to continue with the same medication, observe the patient carefully, and seek for opinions of other physicians. (B) An online survey was conducted; the responses revealed that many physicians would use SGLT2 inhibitors in renal transplant recipients provided the renal function was satisfactory with an eGFR &#x3e; 60. We have learned of an ongoing trial on SGLT2 inhibitors in renal transplant recipients. (C) A case series of 10 patients treated with canagliflozin showed reassuring findings. <b><i>Conclusions:</i></b> Despite the lack of formal trial evidence, the index case suggested the safe use of SGLT2 inhibitors by renal transplant recipients for a remarkably extended period of 2.5 years. Physicians seem willing to use SGLT2 inhibitors in this group of patients provided renal function is satisfactory." @default.
• W2892091729 created "2018-09-27" @default.
• W2892091729 creator A5030037240 @default.
• W2892091729 creator A5031713647 @default.
• W2892091729 creator A5045360789 @default.
• W2892091729 creator A5061392418 @default.
• W2892091729 date "2018-01-01" @default.
• W2892091729 modified "2023-09-26" @default.
• W2892091729 title "Use of SGLT2 Inhibitors in Diabetic Renal Transplant Recipients: A Mixed Method Exploratory Exercise" @default.
• W2892091729 cites W1521639483 @default.
• W2892091729 cites W2061176558 @default.
• W2892091729 cites W2067838047 @default.
• W2892091729 cites W2094470317 @default.
• W2892091729 cites W2146264128 @default.
• W2892091729 cites W2424539745 @default.
• W2892091729 cites W2500767839 @default.
• W2892091729 cites W2606453842 @default.
• W2892091729 cites W2606595268 @default.
• W2892091729 cites W2776157972 @default.
• W2892091729 cites W2793355388 @default.
• W2892091729 doi "https://doi.org/10.1159/000492758" @default.
• W2892091729 hasPublicationYear "2018" @default.
• W2892091729 type Work @default.
• W2892091729 sameAs 2892091729 @default.
• W2892091729 citedByCount "8" @default.
• W2892091729 countsByYear W28920917292019 @default.
• W2892091729 countsByYear W28920917292020 @default.
• W2892091729 countsByYear W28920917292021 @default.
• W2892091729 countsByYear W28920917292022 @default.
• W2892091729 crossrefType "journal-article" @default.
• W2892091729 hasAuthorship W2892091729A5030037240 @default.
• W2892091729 hasAuthorship W2892091729A5031713647 @default.
• W2892091729 hasAuthorship W2892091729A5045360789 @default.
• W2892091729 hasAuthorship W2892091729A5061392418 @default.
• W2892091729 hasBestOaLocation W28920917291 @default.
• W2892091729 hasConcept C126322002 @default.
• W2892091729 hasConcept C134018914 @default.
• W2892091729 hasConcept C2777180221 @default.
• W2892091729 hasConcept C2777422806 @default.
• W2892091729 hasConcept C2780323712 @default.
• W2892091729 hasConcept C2781184683 @default.
• W2892091729 hasConcept C2911091166 @default.
• W2892091729 hasConcept C555293320 @default.
• W2892091729 hasConcept C71924100 @default.
• W2892091729 hasConceptScore W2892091729C126322002 @default.
• W2892091729 hasConceptScore W2892091729C134018914 @default.
• W2892091729 hasConceptScore W2892091729C2777180221 @default.
• W2892091729 hasConceptScore W2892091729C2777422806 @default.
• W2892091729 hasConceptScore W2892091729C2780323712 @default.
• W2892091729 hasConceptScore W2892091729C2781184683 @default.
• W2892091729 hasConceptScore W2892091729C2911091166 @default.
• W2892091729 hasConceptScore W2892091729C555293320 @default.
• W2892091729 hasConceptScore W2892091729C71924100 @default.
• W2892091729 hasIssue "1-4" @default.
• W2892091729 hasLocation W28920917291 @default.
• W2892091729 hasOpenAccess W2892091729 @default.
• W2892091729 hasPrimaryLocation W28920917291 @default.
• W2892091729 hasRelatedWork W2005084305 @default.
• W2892091729 hasRelatedWork W2016264464 @default.
• W2892091729 hasRelatedWork W2033313326 @default.
• W2892091729 hasRelatedWork W2237317573 @default.
• W2892091729 hasRelatedWork W2297099908 @default.
• W2892091729 hasRelatedWork W2462782809 @default.
• W2892091729 hasRelatedWork W2496180703 @default.
• W2892091729 hasRelatedWork W2744240433 @default.
• W2892091729 hasRelatedWork W3167231233 @default.
• W2892091729 hasRelatedWork W4252524655 @default.
• W2892091729 hasVolume "24" @default.
• W2892091729 isParatext "false" @default.
• W2892091729 isRetracted "false" @default.
• W2892091729 magId "2892091729" @default.
• W2892091729 workType "article" @default.